Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Galimberti R et al. – The risk of disseminated strongyloidiasis in patients with impaired cell–mediated immunity is unknown; however, given the poor prognosis of disseminated strongyloidiasis, consideration should be given to the screening of patients at increased risk of infection.

Related Articles

Disseminating best-evidence health-care to Indigenous health-care settings and programs in Australia: identifying the gaps
Health Promotion International, 11/11/09    Relevance Score: 43%

Long-Term Prognosis of Pediatric Patients With Relapsing Acute Disseminated Encephalomyelitis
Journal of Child Neurology, 10/27/09    Relevance Score: 43%

Acute disseminated encephalomyelitis: postinfectious, postimmunization and variant forms
Expert Review of Neurotherapeutics, 10/06/09    Relevance Score: 43%

Eruptive disseminated Spitz naevi: dermatoscopic features
Clinical and Experimental Dermatology, 10/06/09    Relevance Score: 43%

Septic pulmonary emboli secondary to disseminated, community-acquired, methicillin-resistant Staphylococcus aureus infection
Journal of Pediatric Infectious Diseases, 10/15/09    Relevance Score: 42%

Today in Derm Infectious Disease...keeping you current

The 5-D itch scale: a new measure of pruritus
British Journal of Dermatology, 12/10/09

A novel human skin chamber model to study wound infection ex vivo
Archives of Dermatological Research, 12/09/09

Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address